Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)

Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)

Pharmacogenomics (PGx) is a key subset of precision medicine that relates genomic variation to individual response to pharmacotherapy. We assessed longitudinal trends in US FDA approval of new drugs labeled with PGx information. Drug labels containing PGx information were obtained from Drugs@FDA and...

Full description

Bibliographic Details
Main Authors: Jeeyun A. Kim, Rachel Ceccarelli, Christine Y. Lu
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Personalized Medicine
Subjects:
pharmacogenomics
precision medicine
US Food and Drug Administration
clinical actionability
Online Access:https://www.mdpi.com/2075-4426/11/3/179

Similar Items

Similar Items